Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

November 01, 2016

“Forced From Home” Outdoor Exhibition Moves to Independence Mall, Experienced Aid Workers Share Firsthand Accounts of Global Refugee Crisis

October 28, 2016

More than three weeks after Hurricane Matthew swept over southwestern Haiti, thousands of people are still severely affected, with inadequate shelter, food and drinking water, while some remote communities remain cut off and inaccessible.

October 23, 2016

“Forced From Home” Interactive Exhibition Opens at Schenley Plaza, Experienced Aid Workers Give Firsthand Accounts of Global Refugee Crisis

October 12, 2016

“Forced From Home” Interactive Exhibit and Tour Opens at Long Wharf, Experienced Aid Workers Provide Firsthand Accounts of Global Refugee Crisis

September 28, 2016

“Forced From Home” Interactive Exhibit and Tour Opens in Front of the Washington Monument, Experienced Aid Workers Provide First-Hand Accounts of Global Refugee Crisis

September 12, 2016

“Forced From Home” Begins East Coast Tour at the New York Hall of Science

NEW YORK, SEPTEMBER 12, 2016 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) will launch Forced From Home, an interactive, traveling exhibition on the global refugee and migration crisis, this week in New York City.

July 18, 2016

“Forced From Home” Will Tour New York, Washington, D.C., Boston, Pittsburgh and Philadelphia

NEW YORK, JULY 18, 2016 The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) will soon launch a public campaign and interactive exhibit to bring the reality of the global refugee crisis to the American public, the organization announced today.

May 11, 2016

Worst trade deal ever for access to medicines would restrict price-lowering generic competition and promote a broken innovation system

April 27, 2016

MSF hands over global petition as volunteers place 2,500 flowers in front of Pfizer’s headquarters in New York, representing the number of kids who die of pneumonia each day.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

Pages